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ABSTRACT
Aims To assess the effects of adding motivational interviewing (MI) counseling to nicotine patch for smoking cessa-
tion among homeless smokers. Design Two-group randomized controlled trial with 26-week follow-up. Participants
and setting A total of 430 homeless smokers from emergency shelters and transitional housing units in
Minneapolis/St Paul, Minnesota, USA. Intervention and measurements All participants received 8-week treatment
of 21-mg nicotine patch. In addition, participants in the intervention group received six individual sessions of MI
counseling which aimed to increase adherence to nicotine patches and to motivate cessation. Participants in the
standard care control group received one session of brief advice to quit smoking. Primary outcome was 7-day absti-
nence from cigarette smoking at 26 weeks, as validated by exhaled carbon monoxide and salivary cotinine.
Findings Using intention-to-treat analysis, verified 7-day abstinence rate at week 26 for the intervention group was
non-significantly higher than for the control group (9.3% versus 5.6%,P = 0.15). Among participantswho did not quit
smoking, reduction in number of cigarettes from baseline to week 26 was equally high in both study groups
(-13.7  11.9 for MI versus -13.5  16.2 for standard care). Conclusions Adding motivational interviewing coun-
seling to nicotine patch did not increase smoking rate significantly at 26-week follow-up for homeless smokers.
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INTRODUCTION
The prevalence of cigarette smoking among homeless
adults remains an alarming 70–80% or greater [1,2],
which is two to three times that of the general adult popu-
lation in the United States.
Because homeless individuals are faced with meeting
competing basic survival needs such as finding food and
shelter, it is often assumed that smoking cessation is not
a priority for this population. However, recent cross-
sectional surveys showed that homeless smokers reported
a similar level of interest in smoking cessation and quit
attempts compared to the general population of smokers
[3,4]. Nicotine replacement alone or in combinationwith
other treatments was the most preferred treatment
(42.2%), followed by counseling alone or in combination
(24.6%).
Homeless smokers face multiple barriers to accessing
and adhering to treatments [5], such as the daily need
to find food, clothing and shelter as well as practical
limits on accessing and storing medicines. Furthermore,
high rates of psychiatric and other substance abuse
comorbidity conditions [6] within homeless popula-
tions could create additional challenges to adherence to
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smoking cessation treatment and ultimately to smoking
cessation.
While studies on motivational interviewing (MI) for
smoking cessation have yielded mixed results, a recent
meta-analysis (n = 23 studies) suggests that MI outper-
formed comparison conditions significantly at long-term
follow-up points [7]. Also, MI has been shown to improve
treatment adherence and retention [8]. In a pilot study of
nicotine patch use among homeless smokers, MI was
shown to be a feasible and acceptable intervention;
however, MI was not used to address adherence in that
study [9]. To date, there are no controlled trials of inter-
ventions to improve adherence to self-administered medi-
cations that target homeless people specifically. To
address this gap we conducted a smoking cessation ran-
domized clinical trial (RCT) among smokers experiencing
homelessness, called Power To Quit (PTQ). We tested the
hypothesis that MI addressing smoking and nicotine
replacement therapy (NRT) adherence will result in
higher quit rates among homeless smokers compared to
standard care. The current paper describes the smoking
cessation (primary) and NRT adherence (secondary)
outcomes of the study. Understanding the effectiveness
of smoking cessation treatment for this underserved
population will assist researchers and health-care pro-
viders in developing and implementing smoking cessa-
tion interventions for homeless and other vulnerable
populations.
METHODS
Study design
This study was a community-based RCT of 430 homeless
adult cigarette smokers that assessed the effectiveness of
MI for smoking cessation. Participants were randomized
to either the intervention arm (nicotine patch + MI) or
the control arm (nicotine patch + standard care). At
baseline, participants in both groups received a 2-week
supply of 21-mgnicotine patches, and every 2weeks they
received an additional 2-week supply of 21 mg nicotine
patches. Participants randomized to the intervention arm
also received six individual MI counseling sessions, each
lasting 15–20minutes, while participants randomized to
the standard care arm received a one-time brief (10–15
minutes) advice session to quit smoking. Participants pro-
vided written informed consent before they were enrolled
into the study. The study procedures, which have been
published elsewhere [10,11], were approved and moni-
tored by the University of Minnesota’s Institutional
Review Board.
Participant recruitment and randomization
Recruitment occurred fromMay 2009 to August 2010 at
a total of eight homeless shelters in Minneapolis/St Paul,
Minnesota. Recruitment was conducted at health fairs
and via staff informational sessions and posted flyers at
the study sites. Study eligibility criteria included being
currently homeless and having lived in theTwin Cities for
6 months, having smoked at least one cigarette per day
in the past 7 days and at least 100 cigarettes in their
life-time, aged 18 years, and willing to use nicotine
patches for 8 weeks and participate in counseling ses-
sions. Participantswere classified as homeless based upon
the Stewart B. McKinney Act passed by the US congress
in 1987, in which homelessness was defined as anyone
lacking ‘a fixed, regular and adequate nighttime resi-
dence’ or anyone staying at ‘a supervised publicly or pri-
vately operated shelter designed to provide temporary
living accommodations, transitional housing, or other
supportive housing program or a public or private place
not meant for human habitation’ [12]. Smoking status
was confirmed with an exhaled carbon monoxide (CO)
monitor using a cut-off of 5 parts per million (p.p.m.).
Exclusion criteria included: pregnancy, use of another
tobacco cessation aid in the previous 30 days, severe cog-
nitive impairment, suicidal ideation in the last 14 days,
a major medical condition within the prior month or
scoring >5 on items assessing psychotic symptoms from
the nine-item Mini International Neuropsychiatric Inter-
view (MINI) [13].
At the baseline visit, pre-assigned randomization
numbers prepared by the study statistician determined
into which study arm the participant would be enrolled.
The assignment to MI versus standard care was not
blinded to participants. Sequential enrollment continued
until a total of 430 participantswere randomized into the
study.
Treatment period
Eligible participants were scheduled for the baseline
appointment 7–10 days after the initial contact. At the
baseline visit participants were assigned randomly to
either the MI intervention arm or to the standard care
control arm. All participants received a health educa-
tional resource called ‘The Power to Quit: A Quit Smoking
Guide’, a 23-page guide developed by the project investi-
gators. The guide includedmessages on the health risks of
smoking, common reasons for smoking and cognitive
exercises to improve self-directed quit attempts.
Intervention components
Motivational interviewing (MI)
Participants randomized to the MI intervention arm
received six individual MI counseling sessions, each
lasting 15–20 minutes. The MI counseling sessions were
conducted by trained counselors and occurred at baseline
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and follow-up at weeks 1, 2, 4, 6 and 8. The focus of the
MI sessions was encouraging cessation and NRT adher-
ence. Although MI has been used typically to build moti-
vation to quit [7], we also applied the principles and
strategies to encourage adherence to the patch.
Standard care
Participants in the standard care control condition
received a one-time session of brief advice to quit
smoking lasting approximately 10–15minutes and deliv-
ered by trained study counselors [10]. Topics covered in
the standard care session included smoking history,
current smoking, direct advice about the health risks of
smoking and the health benefits of quitting, affirmation
of the participant’s decision to quit, an assessment of
preparedness to quit and addressing strategies for coping
with smoking cues.
Retention
To minimize attrition, study staff made reminder calls to
participants during the week prior to each appointment,
both pending and missed, until the window for complet-
ing appointments closed. Calls were placed from the
project office and made either to each participant’s cell-
phone or to the shelter identified as themost recent night-
time residence in the participant’s file. At each of the 15
visits, participants received incentives. For participants
who attended all 15 sessions, the monetary incentives
totaled $275 over 6 months [10,11].
Measures
All questionnaire items were read to, or along with, the
participants by trained research assistants that included
master’s level public health students, medical students or
community mobilizers. Community mobilizers were indi-
viduals who had experienced homelessness either them-
selves or with a family member. At the baseline visit, we
assessed demographic and smoking behaviors, psychoso-
cial variables, environmental factors and biologicalmeas-
urements. Demographic variables included age, ethnicity,
gender, income, education level, marital status and
employment status and homelessness history, including
duration and type of homelessness. Psychosocial vari-
ables included social support [14,15] and self-efficacy to
refrain from smoking using the Smoking Self-Efficacy
Questionnaire (SEQ-12) [16]. Psychiatric comorbidities
of depression and anxiety were assessed with the four-
item Rost–Burnham screener for depression [17], the
patient health questionnaire (PHQ-9) for depression [18],
the four-item perceived stress scale for stress in past 30
days [19] and the MINI generalized anxiety disorder
assessment [13]. Further, study participants were asked
questions about life-time drug treatment history and
drug and alcohol use and dependence [17]. Adherence to
nicotine patch use wasmeasured by direct observation by
study staff at weeks 2, 4, 6 and 8. Participants were asked
if theywerewearing the patch; for thosewho answered in
the affirmative, study staff then asked to see the patch.
Motivation and confidence for adherence to NRT patch
was assessed with the Motivation/Confidence to Adhere
Scale [20], which is a five-item scale with score range of
1–10 for each item and reflects participants’ level of com-
mitment, desire, need and readiness to adhere to smoking
cessation. Higher totals indicate higher levels of motiva-
tion for adherence (Cronbach’s alpha = 0.84); Self-
Efficacy to Adhere [21] is a modified 10-item Adult AIDS
Clinical Trials Group (AACTG) measure which asks par-
ticipants to indicate their level of confidence in perform-
ing specific adherence tasks relating to treatment.
Responses range from 0 (cannot do at all) to 10 (certain
I can do). Higher scores indicate higher adherence
self-efficacy.
The primary outcome was biochemically verified
self-reported 7-day point prevalence abstinence from
smoking assessed at week 26 post-randomization, defined
as having smoked no cigarettes (not even a puff) during
the previous 7 days. Those who self-reported abstinence
were verified using an expired carbon monoxide
(10 p.p.m.) test. Salivary cotinine testing was per-
formed if the expired CO was greater than 10 p.p.m.
for those who self-reported abstinence. A cut-off of
20 ng/ml for salivary cotinine was used to verify
abstinence. The secondary outcome was adherence
to the nicotine patch, measured by direct observation
at in-person appointments during the treatment
period.
Analysis
The sample size was determined a priori assuming a two-
tailed type I error of 0.05, a power of at least 80% and a
week 26 biochemically verified quit rate of 18% and 8%
for MI intervention and standard care conditions, respec-
tively, based on previous research [9]. The primary analy-
sis was aYates-corrected c2 test of the difference between
the proportions quit in the two groups. With these
assumptions, using the c2 test we needed 214 partici-
pants per study arm. With the final sample of 430
participants achieved, we had 83% power (at a 5%
significance level) to detect statistically significant main
effects. Following intention-to-treat analyses, partici-
pants who did not attend the 26-week visits were
assumed to be smokers. We also compared CO-verified
repeated 7-day abstinence at weeks 8 and 26 using the c2
test as a secondary outcome measure. The repeated point
prevalence abstinence was defined as participants who
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self-reported and verified by CO or cotinine that they were
abstinent both at weeks 8 and 26. All the other par-
ticipants were treated as smokers. We also performed
longitudinal analysis using repeated-measures logistic
regression with generalized estimating equations for the
CO-verified abstinence at weeks 1, 2, 4, 6, 8 and 26,
including time (continuous) and intervention group as
predictors, using PROCGENMOD in SAS version 9.2 (SAS
Institute Inc., 2009 #6990).
RESULTS
Of the 839 individuals screened for study eligibility, 568
were eligible and 430 were randomized, 216 to the MI
intervention and 214 to the control group (Fig. 1). Eligi-
ble participants who returned for randomization were
older and more likely to have a telephone number com-
pared to eligible participants who were not enrolled into
the study. Of the 430 enrolled, 76.1% completed their
week 8 visit (end of treatment) and 75.4% completed the
final week 26 visit. There were no significant differences
in attrition rates (Table 4) between the two study groups.
There were no significant differences in baseline char-
acteristics of participants between treatment groups
(Table 1). Participants’ mean age was 44 years and the
majority were male; African American or white; unem-
ployed; high school graduate or equivalent; with a
monthly income of less than US$400. Nearly two-thirds
reported often sleeping in emergency shelters and 15%
slept in transitional housing in the past 6months. Partici-
pants smoked about a pack of cigarettes a day and 87%
smoked their first cigarette of the day within 30 minutes
of awakening. More than 80% of the sample screened
positive for life-time history of drug abuse or depend-
ence. Self-reported and verified 7-day point prevalence
abstinence rates for the MI and control study groups at
various assessment points are shown in Table 2.
Using intention-to-treat analysis, 7-day verified
smoking abstinence rates at week 8 were 9.3% versus
8.9% (P = 0.89) and at week 26 were 9.3% versus 5.6%
(P = 0.15) for the intervention and control groups,
respectively. The repeated point prevalence abstinence
rate was 3.24% for the MI group and 1.40% for the
standard care group (Fisher’s exact test P = 0.338). We
Assessed for eligibility (n= 839) 
Excluded (n= 271) 
♦ Not meeting inclusion criteria (n= 186) 
♦ Met exclusion criteria (n= 63)
♦ Declined to participate (n= 12) 
♦ Other reasons (n= 10) 
 
Analyzed (n= 214)
♦Excluded from analysis (n= 0) 
Completed final visit = 155 
Lost to follow-up (unable to locate) (n= 55)
Discontinued intervention (n= 4) 
 Reason: unknown (n= 2) 
 Reason: illness (n= 1) 
 Reason: in rehab treatment (n= 1)  
 
Standard Care 
Allocated to intervention (n= 214)
♦ Received allocated intervention (n= 214) 
♦ Did not receive allocated intervention (n= 0) 
Completed final visit =169 
Lost to follow-up (unable to locate) (n= 46) 
Discontinued intervention (n= 1) 
Reason: unknown (n= 1) 
MI Intervention  
Allocated to intervention (n= 216)
♦  Received allocated intervention (n= 216)
♦  Did not receive allocated intervention (n= 0)
Analyzed (n= 216  )
♦  Excluded from analysis (n= 0)
 
Allocation 
Analysis
Follow-Up 
Randomized (n= 430)
Enrollment 
Figure 1 Consolidated Standards of Reporting Trials (CONSORT) [22] flow diagram for the study
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used repeated-measures logistic regression with general-
ized estimating equations (Fig. 2) for the CO-verified
abstinence at weeks 1, 2, 4, 6, 8 and 26, while treating
those lost to follow-up as smokers, and included time
(continuous) and intervention group as predictors. This
yielded an odds ratio for the MI versus standard care
group of 1.33 [95% confidence interval (CI): 0.88, 2.02;
P = 0.17]. If those lost to follow-up were treated as
missing, the odds ratio for the MI versus SC group was
1.40 (95%CI: 0.93, 2.11; P = 0.11). Among participants
that did not quit smoking, reduction in number of ciga-
rettes from baseline to week 26 was equally high in both
study groups (-13.7  11.9 for MI versus -13.5  16.2
for standard care).
Table 3 shows results of various measures of adher-
ence. Motivation for adherence scores at week 6 were
marginally higher for participants in the intervention
group than those in the control group (45.8  6.9 for MI
Table 1 Baseline characteristics of 430 study participants enrolled into the Power to Quit (PTQ) study.
Total
n = 430
Motivational interviewing arm
n = 216
Standard care arm
n = 214
Mean (SD) n Mean (SD) n
Demographic variables
Age, mean  SD, years 44.4 (9.9) 44.5 (9.7) 216 44.2 (10.1) 214
Male, n (%) 321 (74.7) 158 (73.1) 216 163 (76.2) 214
Race/ethnicity, n (%)
African American/black 242 (56.3) 130 (60.2) 216 112 (52.3) 214
White, non-Hispanic 153 (35.6) 69 (31.9) 84 (39.3)
Hispanic/Latino 10 (2.3) 5 (2.3) 5 (2.3)
Native American/Alaska Native 10 (2.3) 5 (2.3) 5 (2.3)
Other 14 (2.3) 7 (3.3) 7 (3.3)
Monthly family income <$400, n (%) 273 (63.5) 140 (64.8) 216 133 (62.1) 214
Education  high school, n (%) 330 (76.8) 166 (76.9) 216 164 (76.6) 214
BMI, mean (SD) 30.1 (7.6) 30.3 (7.8) 215 30.0 (7.5) 211
Psychosocial variables
Depression (PHQ9, in past 2 weeks), mean (SD) 8.5 (6.4) 8.8 (6.7) 216 8.1 (6.1) 212
PHQ9  10 in past 2 weeks, n (%) 148 (34.6) 92 (42.5) 216 81 (38.2) 212
Stress (PSS-4, in past 30 days), mean (SD) 8.4 (2.3) 8.5 (2.5) 215 8.3 (2.1) 213
Tobacco-related variables
Serum cotinine in ng/ml, mean (SD) 213.7 (159.0) 229.2 (179.9) 204 198.3 (133.8) 205
Exhaled carbon monoxide in p.p.m., mean (SD)a 15.6 (9.0) 15.0 (8.3) 202 16.2 (9.65) 207
Cigarettes per day, mean (SD) 19.3 (13.7) 19.1 (11.1) 215 19.4 (16.0) 212
Time to first cigarette, 30 minutes, n (%) 374 (87.0) 188 (87.0) 216 186 (87.0) 270
Smoke menthol cigarettes, n (%) 268 (62.6) 138 (64.2) 216 130 (61.0) 214
Number of 24 hours quit attempts in the past year,
mean (SD)
2.5 (5.2) 2.5 (5.3) 212 2.6 (5.1) 212
Age started smoking regularly, mean (SD) 16.2 (5.9) 16.3 (6.0) 215 16.1 (5.7) 214
Motivation to quit, mean (SD) 9.1 (1.6) 9.0 (1.8) 216 9.1 (1.5) 214
Confidence to quit, mean (SD) 7.3 (2.4) 7.3 (2.4) 216 7.3 (2.5) 214
Substance abuse variables
Ever used illicit druga more than 5 times in life-time,
n (%)
355 (82.8) 182 (84.3) 216 173 (81.2) 213
Ever needed larger amount of illicit drugs to get an
effect, n (%)
170 (39.6) 80 (37.0) 216 90 (42.3) 213
Ever had emotional or psychological problems from
using illicit drugs, n (%)
140 (32.6) 65 (30.1) 216 75 (35.2) 213
Ever thought you were an excessive drinker, n (%) 195 (45.5) 95 (44.0) 216 100 (46.9) 213
Ever drank one-fifth of liquor in one day, n (%) 179 (41.7) 90 (41.7) 216 89 (41.8) 213
Ever drank 7 or more alcoholic drinks daily for 2
weeks, n (%)
174 (40.7) 83 (38.6) 216 91 (42.9) 213
BMI = body mass index; MI = motivational interviewing; SC = standard care; SD = standard deviation; PHQ9 = Patient Health Questionaire-9 Depres-
sion Scale; PSS-4 = Perceived Stress Scale, four items; p.p.m. = parts per million. aList of drugs included marijuana (hashish, pot, grass); amphetami-
nes (stimulants, uppers, speed); barbiturates (sedatives, downers, sleeping pills, Seconal, Quaaludes); tranquilizers (Valium, Librium); cocaine (coke,
crack); heroin; opiates (codeine, Demerol, morphine, methadone, Darvon, opium), psychedelics [lysergic acid diethylamide (LSD),
mescaline, peyote, psilocybin, dimethyltryptamine (DMT), phencyclidine (PCP)].
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versus 44.4  7.4 for control, P = 0.08). Table 3 also
shows results of ‘patch checks’, i.e. the proportion of par-
ticipants who had their nicotine patches on at various
study visits. There were no differences between study
groups in the proportion of participants who had their
nicotine patches on at various study visits. Table 4 shows
the attendance for various study contact points.
DISCUSSION
Results from this study show that verified quit rates at
weeks 8 and 26 for MI were not significantly better than
those for standard care. Although the quit rates for MI
were consistently higher at all study time-points, the
magnitude of the effects was small.
The 9.3% verified quit rate at week 26 is comparable
to findings from a cluster-randomized trial that tested
Table 2 Self-report and biochemically verified 7-day point-
prevalence abstinence rates of 430 study participants enrolled
into the Power to Quit (PTQ) study.a
MI Standard care P-value
Self-report
Quit at week 8, n (%) 33 (15.28%) 26 (12.15%) 0.350
Quit at week 26, n (%) 36 (16.67%) 25 (11.68%) 0.140
Verified
Quit at week 8, n (%) 20 (9.26%) 19 (8.88%) 0.890
Quit at week 26 n (%)b 20 (9.26%) 12 (5.61%) 0.150
aThose lost to follow-up were treated as smokers; bcarbon monoxide
(10 parts per million) or cotinine (20 ng/ml) verified. MI =
motivational interviewing.
0
2
4
6
8
10
12
1 2 4 6 8 26
MI
SC
Follow-up weeks
P
er
ce
nt
 a
bs
ti
ne
nt
Figure 2 Verified abstinence by time
Table 4 Summary of attendance at study visits of 430 study
participants enrolled into the Power to Quit (PTQ) study.
Study visit
time-points
Study visit completed
SC (n = 214) MI (n = 216)
n % n %
Week 1 191 89.3 189 87.5
Week 2 190 88.8 172 79.6
Week 4 184 86.0 174 80.6
Week 6 171 79.9 159 73.6
Week 8 168 78.5 162 75.0
Week 10 146 68.2 145 67.1
Week 12 143 66.8 155 71.8
Week 14 140 65.4 145 67.1
Week 16 137 64.0 143 66.2
Week 18 142 66.4 146 67.6
Week 20 136 63.6 146 67.6
Week 22 139 65.0 155 71.8
Week 24 141 65.9 156 72.2
Week 26 155 72.4 169 78.2
SC = standard care; MI = motivational interviewing.
Table 3 Adherence measures of 430 study participants enrolled into the Power to Quit (PTQ) study.
Variables
Total
(n = 430)
MI
(n = 216)
Standard care
(n = 214) P-value
Baseline motivation to adhere, mean (SD) 45.4 (6.5) 45.4 (6.3) 45.3 (6.7) 0.77
Week 6 motivation to adhere, mean (SD) 45.1 (7.3) 45.8 (7.0) 44.4 (7.5) 0.08
Motivation to adhere change in scores from baseline to week 6,
mean (SD)
0.02 (8.2) 0.4 (8.4) -0.4 (8.1) 0.40
Baseline self-efficacy to adhere, mean (SD) 78.4 (17.6) 78.2 (18.0) 78.7 (17.1) 0.76
Week 6 self-efficacy to adhere, mean (SD) 84.1 (18.3) 85.4 (19.1) 82.9 (17.5) 0.22
Self-efficacy to adhere change in scores from baseline to week 6,
mean (SD)
5.7 (20.8) 5.7 (22.5) 5.7 (19.2) 0.99
Had nicotine patch on at visit (‘patch check’), % yes
Week 1 52.8 49.1 56.5 0.12
Week 2 52.6 49.1 56.1 0.15
Week 4 44.7 46.8 42.5 0.38
Week 6 38.6 40.7 36.5 0.36
Week 8 33.7 33.8 33.7 0.97
SD = standard deviation; MI = motivational interviewing.
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nicotine gum plus five MI sessions for smoking cessation
in 20 low-income housing developments (n = 173) [23].
For that study, biochemically verified 7-day abstinence
rates were 6.1% versus 5.6% at week 8 and 7.6% versus
9.3% at week 26 for the intervention and comparison
groups, respectively. However, the quit rates in our
current study are lower than rates reported from two
pilot studies with homeless smokers [9,24]. In one study
(n = 46) [9], which utilized five individual MI, six group
meetings and a choice of NRT, CO-verified abstinence
rates at week 26 were 17.4% versus 8.7% for interven-
tion and comparison groups, respectively. The second
study [24] (n = 58), which had no control group, tested
the effects of a 12-week group cognitive–behavioral
therapy and choice of NRT, bupropion or varenicline
and reported a CO-verified quit rate of 13.6% at 24
weeks. These pilot studies had more intensive counseling
interventions that may have contributed to higher quit
rates. There are other reasons that could contribute to
the low quit rates in our current study. In addition to
multiple competing challenges that being homeless
could pose to smoking cessation, our study sample had
characteristics suggestive of high nicotine dependence,
including factors such as smoking a pack of cigarettes
per day on average, and nearly all participants smoked
their first cigarette of the day within 30 minutes of
awakening.
In addition, our study sample showed high rates of
comorbidities with depression, alcohol and other sub-
stance abuse, with nearly 40% having PHQ-9 scores in
the moderate or worse depression range; nearly half con-
sidered themselves as alcoholic or chemically dependent.
Studies in other populations have shown that these
comorbidities make quitting smoking more challenging
[2,25,26]. In essence, our study had a lower dose of
counseling and higher rate of comorbidities than the two
studies described above. Unlike the protocol of most
smoking cessation studies in the general population, that
excludes smokers with these comorbid conditions,
smokers with these conditions were allowed to enroll in
this study provided they were medically stable, as deter-
mined by a psychiatrist. This protocol decision was made
to ensure that the study sample was similar to homeless
smokers in general, which would enhance the study’s
external validity.
Given the challenges to smoking cessation in homeless
populations, it could be argued that even these low ces-
sation rates are probably higher than secular trends in
this population and are therefore encouraging. These
results highlight that homeless smokers are interested in
quitting smoking and will enroll in a smoking cessation
trial. Also, 75% of eligible participants returned for ran-
domization and 75% of those enrolled completed their
final week 26 visit. These results, regarding interest
within homeless populations in smoking cessation, are
consistent with findings from earlier studies [3,27,28].
However, these findings are in direct contrast to the pre-
sumption by some that homeless people would not be
interested in smoking cessation due to many competing
daily challenges, or that follow-up for longitudinal studies
would be nearly impossible because of their transient
housing situation.
This study also found that, contrary to expectations,
MI did not improve adherence measures among partici-
pants who receivedMI.The lack of effect of MI to promote
treatment adherence is contrary to several studies [8]
that have reported large effects of MI in promoting treat-
ment adherence. It should be noted, however, that despite
not requiringmotivation to quit or adhere to treatment as
study enrollment criteria in the current study, partici-
pants reported highmotivation to quit smoking as well as
high motivation and self-efficacy to adhere to nicotine
patch use. Having less favorable outcomes withMI is con-
sistent with other studies in non-homeless settings that
have shown that MI works better among people who are
resistant, angry or demonstrate low motivation to
change a particular health behavior [29], and therefore
may be contraindicated for patients who are ready for
action. Another study [30], in a non-homeless sample,
found that MI was less effective than health education for
smoking cessation among a sample of African American
light smokers whowere highlymotivated to quit smoking
at study enrollment.
This study hasmany strengths.To our knowledge, this
is the largest and the first adequately powered rand-
omized smoking cessation clinical trial in homeless popu-
lations. We successfully randomized a diverse sample of
430 homeless smokers in 15 months. We were able to
achieve a study sample that is reflective of the general
homeless population of the same community [1,31]. We
also achieved 75% retention for 26 weeks. This suggests
that smokers, regardless of their housing situation, want
to quit and can be successful in doing so when provided
with the opportunity.
This study has limitations. First, it was conducted at a
single metropolitan area in the upper Midwest of the
United States and there may be differences between cities,
states or regions within a country and between countries
that limit external validity. However, this generalizability
concern is somewhat mitigated by the fact that partici-
pants were recruited from a variety of emergency shelters
and transitional housing units. Data about emergency
shelters from a tri-annual state-wide survey (Wilder
Foundation, 2009 #5998) shows that the mean age for
homeless people in Hennepin and Ramsey Counties
encompassing the Twin Cities were 42.4 years and 42.9
years, respectively, compared to 44.4 years in our study
sample. Also, our study sample was 74.7%male, which is
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© 2013 Society for the Study of Addiction Addiction, 108, 1136–1144
comparable to that in Hennepin (72.7%) but lower than
that in Ramsey (86.5%) Counties [31]. Secondly, because
this was a treatment study, the sample was self-selected
and motivated to quit smoking and thus may not be rep-
resentative of homeless smokers generally.The highmoti-
vation of participants may also have made MI less
effective, as MI is best suited for less motivated people
[7,30]. However, the sample represents the group of
smokers who would seek smoking cessation treatment if
it were to become available in homeless populations.
Our results reveal that despite many competing daily
challenges, homeless smokers are interested in smoking
cessation and that motivational interviewing and nico-
tine replacement showed promising effects for smoking
cessation for homeless populations. The low quit rate in
this study calls for more studies and programs to enhance
smoking cessation rates in homeless populations. It is
possible that other counseling approaches, besides MI,
might be more effective, or perhaps more intensive inter-
ventions are needed for smokers experiencing homeless-
ness. Due to the high rates of psychiatric and substance
abuse comorbidities in this population, will intervening
in these comorbid conditions concurrently or in sequence
result in improved smoking cessation rates? Because of
the strikingly high prevalence of smoking and associated
morbidity in homeless populations, developing and
implementing programs to improve smoking cessation
outcomes is critical for reducing the tobacco-related
health disparities in homeless and other underserved
populations.
Clinical trial registration
Trial Registration: clinicaltrials.gov: NCT00786149.
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